Skip to main content
Top
Published in: Cardiovascular Toxicology 3/2018

01-06-2018

Inhibition of the Voltage-Dependent K+ Current by the Tricyclic Antidepressant Desipramine in Rabbit Coronary Arterial Smooth Muscle Cells

Authors: Sung Eun Shin, Hongliang Li, Jin Ryeol An, Mi Seon Seo, Sung Hun Na, Won-Kyo Jung, Amy L. Firth, Kwon-Soo Ha, Eun-Taek Han, Seok-Ho Hong, Il-Whan Choi, Won Sun Park

Published in: Cardiovascular Toxicology | Issue 3/2018

Login to get access

Abstract

We describe the effect of a tricyclic antidepressant drug desipramine on voltage-dependent K+ (Kv) currents in freshly isolated rabbit coronary arterial smooth muscle cells using a conventional whole-cell patch clamp technique. Application of desipramine rapidly decreased the Kv current amplitude in a concentration-dependent manner, with an IC50 value of 5.91 ± 0.18 μM and a Hill coefficient of 0.61 ± 0.09. The steady-state inactivation curves of the Kv channels were not affected by desipramine. However, desipramine shifted the steady-state inactivation curves toward a more negative potential. Application of train pulses (1 or 2 Hz) slightly reduced the Kv current amplitude. Such reduction in the Kv current amplitude by train pulses increased in the presence of desipramine. Furthermore, the inactivation recovery time constant was also increased in the presence of desipramine, suggesting that desipramine-induced inhibition of the Kv current was use-dependent. Application of a Kv1.5 inhibitor (DPO-1) and/or a Kv2.1 inhibitor (guangxitoxin) did not change the inhibitory effect of desipramine on Kv currents. Based on these results, we concluded that desipramine directly inhibited the Kv channels in a dose- and state-dependent manner, but the effect was independent of norepinephrine/serotonin reuptake inhibition.
Appendix
Available only for authorised users
Literature
1.
go back to reference DeVane, C. L. (1998). Differential pharmacology of newer antidepressants. Journal of Clinical Psychiatry, 59, 85–93.CrossRefPubMed DeVane, C. L. (1998). Differential pharmacology of newer antidepressants. Journal of Clinical Psychiatry, 59, 85–93.CrossRefPubMed
2.
go back to reference Von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M., & Kriston, L. (2013). Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis. Journal of Affective Disorders, 144, 7–15.CrossRef Von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M., & Kriston, L. (2013). Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis. Journal of Affective Disorders, 144, 7–15.CrossRef
3.
go back to reference Luo, L., Xie, Y., Wang, A., Liu, X., Xiao, F., Zhong, X., et al. (2014). Desipramine ameliorates Cr(VI)-induced hepatocellular apoptosis via the inhibition of ceramide channel formation and mitochondrial PTP opening. Cellular Physiology and Biochemistry, 34, 2128–2136.CrossRefPubMed Luo, L., Xie, Y., Wang, A., Liu, X., Xiao, F., Zhong, X., et al. (2014). Desipramine ameliorates Cr(VI)-induced hepatocellular apoptosis via the inhibition of ceramide channel formation and mitochondrial PTP opening. Cellular Physiology and Biochemistry, 34, 2128–2136.CrossRefPubMed
4.
go back to reference Brielmaier, J., Senerth, J. M., Silverman, J. L., Matteson, P. G., Millonig, J. H., DiCicco-Bloom, E., et al. (2014). Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes, Brain and Behavior, 13, 286–298.CrossRef Brielmaier, J., Senerth, J. M., Silverman, J. L., Matteson, P. G., Millonig, J. H., DiCicco-Bloom, E., et al. (2014). Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes, Brain and Behavior, 13, 286–298.CrossRef
5.
go back to reference Mokhber, N., Abdollahian, E., Soltanifar, A., Samadi, R., Saghebi, A., Haghighi, M. B., et al. (2014). Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients. Pharmacopsychiatry, 47, 131–140.CrossRefPubMed Mokhber, N., Abdollahian, E., Soltanifar, A., Samadi, R., Saghebi, A., Haghighi, M. B., et al. (2014). Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients. Pharmacopsychiatry, 47, 131–140.CrossRefPubMed
6.
go back to reference Rudorfer, M. V., & Young, R. C. (1980). Anticholinergic effects and plasma desipramine levels. Clinical Pharmacology and Therapeutics, 28, 703–705.CrossRefPubMed Rudorfer, M. V., & Young, R. C. (1980). Anticholinergic effects and plasma desipramine levels. Clinical Pharmacology and Therapeutics, 28, 703–705.CrossRefPubMed
7.
go back to reference White, N. C., Litovitz, T., & Clancy, C. (2008). Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology, 4, 238–250.CrossRefPubMedPubMedCentral White, N. C., Litovitz, T., & Clancy, C. (2008). Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology, 4, 238–250.CrossRefPubMedPubMedCentral
8.
go back to reference Zahradnik, I., Minarovic, I., & Zahradniková, A. (2008). Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics, 324, 977–984.CrossRefPubMed Zahradnik, I., Minarovic, I., & Zahradniková, A. (2008). Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics, 324, 977–984.CrossRefPubMed
9.
go back to reference Staudacher, I., Wang, L., Wan, X., Obers, S., Wenzel, W., Tristram, F., et al. (2011). hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn-Schmiedeberg’s Archives of Pharmacology, 383, 119–139.CrossRefPubMed Staudacher, I., Wang, L., Wan, X., Obers, S., Wenzel, W., Tristram, F., et al. (2011). hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn-Schmiedeberg’s Archives of Pharmacology, 383, 119–139.CrossRefPubMed
10.
go back to reference Dick, G. M., Bratz, I. Z., Borbouse, L., Payne, G. A., Dincer, U. D., Knudson, J. D., et al. (2008). Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. American Journal of Physiology Heart and Circulatory Physiology, 294, 2371–2381.CrossRef Dick, G. M., Bratz, I. Z., Borbouse, L., Payne, G. A., Dincer, U. D., Knudson, J. D., et al. (2008). Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. American Journal of Physiology Heart and Circulatory Physiology, 294, 2371–2381.CrossRef
11.
go back to reference Li, H., Hong, D. H., Kim, H. S., Kim, H. W., Jung, W. K., Na, S. H., et al. (2015). The calmodulin inhibitor CGS 9343B inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Toxicology and Applied Pharmacology, 15, 207–213.CrossRef Li, H., Hong, D. H., Kim, H. S., Kim, H. W., Jung, W. K., Na, S. H., et al. (2015). The calmodulin inhibitor CGS 9343B inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Toxicology and Applied Pharmacology, 15, 207–213.CrossRef
12.
go back to reference Nelson, M. T., & Quayle, J. M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. American Journal of Physiology, 268, 799–822.CrossRef Nelson, M. T., & Quayle, J. M. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. American Journal of Physiology, 268, 799–822.CrossRef
13.
go back to reference Ko, E. A., Han, J., Jung, I. D., & Park, W. S. (2008). Physiological roles of K+ channels in vascular smooth muscle cells. Journal of Smooth Muscle Research, 44, 65–81.CrossRefPubMed Ko, E. A., Han, J., Jung, I. D., & Park, W. S. (2008). Physiological roles of K+ channels in vascular smooth muscle cells. Journal of Smooth Muscle Research, 44, 65–81.CrossRefPubMed
14.
go back to reference Shimoda, L. A., Sylvester, J. T., & Sham, J. S. (1998). Inhibition of voltage-dependent K+ currents in rat intrapulmonary arterial myocytes by endothelin-1. American Journal of Physiology, 274, 842–853. Shimoda, L. A., Sylvester, J. T., & Sham, J. S. (1998). Inhibition of voltage-dependent K+ currents in rat intrapulmonary arterial myocytes by endothelin-1. American Journal of Physiology, 274, 842–853.
15.
go back to reference Bae, Y. M., Kim, A., Kim, J., Park, W. S., Kim, T. K., Lee, Y. R., et al. (2006). Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+ currents. Biochemical and Biophysical Research Communications, 347, 468–476.CrossRefPubMed Bae, Y. M., Kim, A., Kim, J., Park, W. S., Kim, T. K., Lee, Y. R., et al. (2006). Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+ currents. Biochemical and Biophysical Research Communications, 347, 468–476.CrossRefPubMed
16.
go back to reference Doyon, G., & Bruemmer, D. (2016). Vascular smooth muscle cell dysfunction in diabetes: Nuclear receptors channel to relaxation. Clinical Science, 130, 1837–1839.CrossRefPubMed Doyon, G., & Bruemmer, D. (2016). Vascular smooth muscle cell dysfunction in diabetes: Nuclear receptors channel to relaxation. Clinical Science, 130, 1837–1839.CrossRefPubMed
17.
go back to reference Liu, Y., & Gutterman, D. D. (2002). The coronary circulation in diabetes: Influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascular Pharmacology, 38, 43–49.CrossRefPubMed Liu, Y., & Gutterman, D. D. (2002). The coronary circulation in diabetes: Influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascular Pharmacology, 38, 43–49.CrossRefPubMed
18.
go back to reference Archer, S. L., London, B., Hampl, V., Wu, X., Nsair, A., Puttagunta, L., et al. (2001). Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. The FASEB Journal, 15, 1801–1803.CrossRefPubMed Archer, S. L., London, B., Hampl, V., Wu, X., Nsair, A., Puttagunta, L., et al. (2001). Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. The FASEB Journal, 15, 1801–1803.CrossRefPubMed
19.
go back to reference Cox, R. H., Folander, K., & Swanson, R. (2001). Differential expression of voltage-gated K+ channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension, 37, 1315–1322.CrossRefPubMed Cox, R. H., Folander, K., & Swanson, R. (2001). Differential expression of voltage-gated K+ channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension, 37, 1315–1322.CrossRefPubMed
20.
go back to reference Gillman, P. K. (2007). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology, 151, 737–748.CrossRefPubMedPubMedCentral Gillman, P. K. (2007). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology, 151, 737–748.CrossRefPubMedPubMedCentral
21.
go back to reference Lin, Z. Y., Chen, L. M., Zhang, J., Pan, X. D., Zhu, Y. G., Ye, Q. Y., et al. (2012). Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacologica Sinica, 33, 438–444.CrossRefPubMedPubMedCentral Lin, Z. Y., Chen, L. M., Zhang, J., Pan, X. D., Zhu, Y. G., Ye, Q. Y., et al. (2012). Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacologica Sinica, 33, 438–444.CrossRefPubMedPubMedCentral
22.
go back to reference Wu, S. N., Hsu, M. C., Liao, Y. K., Wu, F. T., Jong, Y. J., & Lo, Y. C. (2012). Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evidence-Based Complementary and Alternative Medicine, 2012, 148–403. Wu, S. N., Hsu, M. C., Liao, Y. K., Wu, F. T., Jong, Y. J., & Lo, Y. C. (2012). Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evidence-Based Complementary and Alternative Medicine, 2012, 148–403.
23.
go back to reference Kim, J. M., Park, W. S., Lin, H. Y., Shin, K. C., Sung, D. J., Kim, J. G., et al. (2015). Blockade of voltage-gated K+ currents in rat mesenteric arterial smooth muscle cells by MK801. Journal of Pharmacological Sciences, 127, 92–102.CrossRefPubMed Kim, J. M., Park, W. S., Lin, H. Y., Shin, K. C., Sung, D. J., Kim, J. G., et al. (2015). Blockade of voltage-gated K+ currents in rat mesenteric arterial smooth muscle cells by MK801. Journal of Pharmacological Sciences, 127, 92–102.CrossRefPubMed
24.
go back to reference Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Jung, W. K., Ha, K. S., et al. (2017). The selective serotonin reuptake inhibitor dapoxetine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Clinical and Experimental Pharmacology and Physiology, 44, 480–487.CrossRefPubMed Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Jung, W. K., Ha, K. S., et al. (2017). The selective serotonin reuptake inhibitor dapoxetine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Clinical and Experimental Pharmacology and Physiology, 44, 480–487.CrossRefPubMed
25.
go back to reference Carignani, C., & Corsi, M. (2002). Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine. European Journal of Pharmacology, 448, 139–142.CrossRefPubMed Carignani, C., & Corsi, M. (2002). Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine. European Journal of Pharmacology, 448, 139–142.CrossRefPubMed
26.
go back to reference Shin, S. E., Li, H., Kim, H. S., Kim, H. W., Seo, M. S., Ha, K. S., et al. (2017). Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 225–232.CrossRef Shin, S. E., Li, H., Kim, H. S., Kim, H. W., Seo, M. S., Ha, K. S., et al. (2017). Nortriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 225–232.CrossRef
27.
go back to reference Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Choi, I. W., Firth, A. L., et al. (2016). Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Journal of Biosciences, 41, 659–666.CrossRefPubMed Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Choi, I. W., Firth, A. L., et al. (2016). Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Journal of Biosciences, 41, 659–666.CrossRefPubMed
28.
go back to reference Hong, D. H., Li, H., Kim, H. S., Kim, H. W., Shin, S. E., Jung, W. K., et al. (2015). The effects of the selective serotonin reuptake inhibitor fluvoxamine on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Biological and Pharmaceutical Bulletin, 38, 1208–1213.CrossRefPubMed Hong, D. H., Li, H., Kim, H. S., Kim, H. W., Shin, S. E., Jung, W. K., et al. (2015). The effects of the selective serotonin reuptake inhibitor fluvoxamine on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. Biological and Pharmaceutical Bulletin, 38, 1208–1213.CrossRefPubMed
29.
go back to reference Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Seo, M. S., An, J. R., et al. (2017). Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 415–421.CrossRef Kim, H. S., Li, H., Kim, H. W., Shin, S. E., Seo, M. S., An, J. R., et al. (2017). Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. The Korean Journal of Physiology & Pharmacology, 21, 415–421.CrossRef
30.
go back to reference Xu, C., Lu, Y., Tang, G., & Wang, R. (1999). Expression of voltage-dependent K+ channel genes in mesenteric artery smooth cells. American Journal of Physiology, 277, 1055–1063. Xu, C., Lu, Y., Tang, G., & Wang, R. (1999). Expression of voltage-dependent K+ channel genes in mesenteric artery smooth cells. American Journal of Physiology, 277, 1055–1063.
31.
go back to reference Yuan, X. J., Wang, J., Juhaszova, M., Golovina, V. A., & Rubin, L. J. (1998). Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. American Journal of Physiology, 274, 621–635. Yuan, X. J., Wang, J., Juhaszova, M., Golovina, V. A., & Rubin, L. J. (1998). Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. American Journal of Physiology, 274, 621–635.
32.
go back to reference Nichols, A. I., Abell, M., Chen, Y., Behrle, J. A., Frick, G., Paul, J., et al. (2013). Effect of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults. International Clinical Psychopharmacology, 28, 99–105.CrossRefPubMed Nichols, A. I., Abell, M., Chen, Y., Behrle, J. A., Frick, G., Paul, J., et al. (2013). Effect of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults. International Clinical Psychopharmacology, 28, 99–105.CrossRefPubMed
Metadata
Title
Inhibition of the Voltage-Dependent K+ Current by the Tricyclic Antidepressant Desipramine in Rabbit Coronary Arterial Smooth Muscle Cells
Authors
Sung Eun Shin
Hongliang Li
Jin Ryeol An
Mi Seon Seo
Sung Hun Na
Won-Kyo Jung
Amy L. Firth
Kwon-Soo Ha
Eun-Taek Han
Seok-Ho Hong
Il-Whan Choi
Won Sun Park
Publication date
01-06-2018
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 3/2018
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-017-9435-x

Other articles of this Issue 3/2018

Cardiovascular Toxicology 3/2018 Go to the issue